The first prospective, randomized clinical trial of cell culture drug resistance testing (guided by the results of the DiSC Assay) was undertaken in the United Kingdom (UK). It was part of a large trial in which 750 newly-diagnosed patients were enrolled. This was the first prospective, randomized clinical trial to document that performing any type of laboratory or radiographic test in any form of cancer makes a difference with respect to treatment outcome.